Related references
Note: Only part of the references are listed.Therapeutic efficacy of azaindole-1 in experimental pulmonary hypertension
B. K. Dahal et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents
Mohamed Izikki et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Role of the prostanoid EP4 receptor in iloprost-mediated vasodilatation in pulmonary hypertension
Ying-Ju Lai et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Activation of protein kinase A stimulates the progesterone-induced calcium influx in human sperm exposed to the phosphodiesterase inhibitor papaverine
Victor Torres-Flores et al.
JOURNAL OF ANDROLOGY (2008)
PDE-10A inhibitors as insulin secretagogues
Louis-David Cantin et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Phosphodiesterase 1 upregulation in pulmonary arterial hypertension target for reverse-remodeling therapy
Ralph Theo Schermuly et al.
CIRCULATION (2007)
Role of phosphodiesterases in neurological and psychiatric disease
Andrea L. O. Hebb et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Expression and activity of cAMP phosphodiesterase isoforms in pulmonary artery smooth muscle cells from patients with pulmonary hypertension: role for PDE1
Fiona Murray et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Systems analysis of PKA-mediated phosphorylation gradients in live cardiac myocytes
Jeffrey J. Saucerman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Role of nuclear Ca2+/calmodulin-stimulated phosphodiesterase 1A in vascular smooth muscle cell growth and survival
DJ Nagel et al.
CIRCULATION RESEARCH (2006)
Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents
C Lugnier
PHARMACOLOGY & THERAPEUTICS (2006)
cAMP is a ligand for the tandem GAF domain of human phosphodiesterase 10 and cGMP for the tandem GAF domain of phosphodiesterase 11
M Gross-Langenhoff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
siRNA-induced caveolin-1 knockdown in mice increases lung vascular permeability via the junctional pathway
K Miyawaki-Shimizu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2006)
Sildenafil citrate therapy for pulmonary arterial hypertension
N Galiè et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Inhaled tolafentrine reverses pulmonary vascular remodeling via inhibition of smooth muscle cell migration
S Pullamsetti et al.
RESPIRATORY RESEARCH (2005)
Reversal of experimental pulmonary hypertension by PDGF inhibition
RT Schermuly et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Epidermal growth factor receptor blockade mediates smooth muscle cell apoptosis and improves survival in rats with pulmonary hypertension
SL Merklinger et al.
CIRCULATION (2005)
Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells
J Wharton et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Arrestin times for compartmentalised cAMP signalling and phosphodiesterase-4 enzymes
GS Baillie et al.
CURRENT OPINION IN CELL BIOLOGY (2005)
cAMP phosphodiesterase inhibitors potentiate effects of prostacyclin analogs in hypoxic pulmonary vascular remodeling
PG Phillips et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2005)
Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension
RT Schermuly et al.
CIRCULATION RESEARCH (2004)
Bicarbonate-responsive soluble adenylyl cyclase defines a nuclear cAMP microdomain
JH Zippin et al.
JOURNAL OF CELL BIOLOGY (2004)
Chronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in rats
RT Schermuly et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Prostacylin receptor activation inhibits proliferation of aortic smooth muscle cells by regulating cAMP response element-binding protein- and pocket protein-dependent cyclin A gene expression
D Kothapalli et al.
MOLECULAR PHARMACOLOGY (2003)
Inhaled iloprost for severe pulmonary hypertension
H Olschewski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Bosentan therapy for pulmonary arterial hypertension
LJ Rubin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
cAMP response element-binding protein content is a molecular determinant of smooth muscle cell proliferation and migration
DJ Klemm et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions
SH Soderling et al.
CURRENT OPINION IN CELL BIOLOGY (2000)
Cyclic AMP inhibited proliferation of human aortic vascular smooth muscle cells, accompanied by induction of p53 and p21
S Hayashi et al.
HYPERTENSION (2000)
Share Paper
